CPI-1205 Completed Phase 1 Trials for B-Cell Lymphoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02395601A Study Evaluating CPI-1205 in Patients With B-Cell Lymphomas